New research on parasitic worm

  • April 23, 2014
New research on parasitic worm

New research which moves scientists one step closer to finding a vaccine for a parasitic worm that infects more than 200 million people worldwide has been published.

New research which moves scientists one step closer to finding a vaccine for a parasitic worm that infects more than 200 million people worldwide has been published.

The research, led by Gates Cambridge Alumnus Sukrit Silas, is in the International Journal for Parasitology.

Infection by the parasitic worm Schistosoma mansoni occurs in 54 countries around the world and is a serious health problem in sub-Saharan Africa. Symptoms can include fever, a rash, aching, a cough, diarrheoa and gland enlargement. For those living where the parasite is endemic, repeated exposure can lead to life-long infection, although partial immunity does eventually develop. Infection by the worm is second only to malaria in its global impact on human populations. Over the past two decades, it has been argued that a particular kind of antibody response in chronic patients of schistosomiasis – known as Immunoglobulin E (IgE) – might serve to protect people from reinfection by the parasite.

It has also become clear that IgE-mediated immune responses play a central role in allergies, leading some scientists to propose that allergies might simply be misguided anti-parasite responses. This means for example, that people with allergies to shellfish might develop rashes and inflammation upon exposure to shrimp because their immune system “thinks” it is under parasitic attack and mounts an aggressive defence.

Sukrit [2011], whose work is based on his MPhil in Pathology, which was supported by a Gates Cambridge Scholarship, says: “In this research, we turned this idea on its head, and argued that in order to find “signatures” of the parasite that might be easy for the human immune system to recognise, our best bet would be to look for worm proteins that “look like” already known allergens. Such protein signatures could then be purified and used to immunise people who live in endemic regions against schistosomiasis. We first purified and characterised several different variants of S. mansoni tropomyosin – a predominantly muscle-related protein that is present in all animals and is the major food allergen in shellfish. We then tested whether blood serum from chronically infected patients in Musoli – a fishing village in Uganda – contained antibodies against these purified tropomyosins, and whether these immune responses were correlated with resistance to reinfection. Indeed, we found that IgE responses to one tropomyosin variant in S. mansoni were significantly correlated with immunity.”

Sukrit is currently at Stanford University where he is doing a PhD in Chemical and Systems Biology.

*Picture credit: Wiki Commons and US Army Africa. It depicts the Medical Civic Action Programme in Shinile Woreda, Ethiopia, 2010.

Latest News

Shaping policy and Alzheimer’s research

Just six years since leaving Cambridge, Brianne Kent has secured a role as Assistant Professor, won multiple awards,  become the first early career researcher on the Governing Council of the Canadian Institutes of Health Research [CIHR] and is currently setting up her own laboratory to further her studies on Alzheimer’s disease. Since January, when she […]

Ed-tech wins Gates Foundation funding for access work

An ed-tech non-profit co-founded by a Gates Cambridge Scholar has received a $980,000 grant from the Bill & Melinda Gates Foundation to develop its free college affordability tool. Moneythink, co-founded by Greg Nance who is also its Board Chair, says the money will help it to accelerate the development and reach of DecidED, its free […]

Gates Cambridge: a purposeful community

As the Gates Cambridge Scholarship reaches the end of its 20th anniversary year, its alumni association is holding an event late this month which celebrates some of the factors that have shaped the scholar community. That sense of community, of a global network of leaders, developed and owned by the scholars and alumni themselves, is […]

Fibre optic project aims to improve Sri Lanka’s infrastructure

A Gates Cambridge Alumnus has formed a partnership between his university, Cambridge and Oxford universities and a local engineering company to introduce a cutting-edge technology to Sri Lanka. A team of researchers and industry experts from the University of Moratuwa in Sri Lanka, the Cambridge Centre for Smart Infrastructure and Construction (CSIC), the University of […]